Autologous Hematopoietic Cell Transplant (AHCT) Offers Prolonged Progression Free and Overall Survival in Patients with Light Chain Amyloidosis (AL) Compared with Chemotherapy Alone
| Autor: | Rebecca R. Hung, Madan Jagasia, Oluchi C. Ukaegbu, Tarsheen K. Sethi, Stacey Goodman, Robert F. Cornell, David Slosky, Adetola A. Kassim, Samuel M. Rubinstein, Daniel J. Lenihan, Shelton Lacy, Anthony Langone, Bipin N. Savani |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Oncology
Transplantation Pathology medicine.medical_specialty Chemotherapy Hematopoietic cell business.industry Amyloidosis medicine.medical_treatment Hematology 030204 cardiovascular system & hematology Immunoglobulin light chain medicine.disease 03 medical and health sciences 0302 clinical medicine Internal medicine medicine Overall survival In patient 030212 general & internal medicine business |
| Zdroj: | Biology of Blood and Marrow Transplantation. 22:S233-S234 |
| ISSN: | 1083-8791 |
| DOI: | 10.1016/j.bbmt.2015.11.642 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect